Adverum Biotechnologies
ADVM
ADVM
118 hedge funds and large institutions have $279M invested in Adverum Biotechnologies in 2021 Q2 according to their latest regulatory filings, with 22 funds opening new positions, 45 increasing their positions, 29 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
70% less capital invested
Capital invested by funds: $937M → $279M (-$658M)
Holders
118
Holding in Top 10
2
Calls
$4.26M
Puts
$4.27M
Top Buyers
| 1 | +$15.1M | |
| 2 | +$5.69M | |
| 3 | +$3.14M | |
| 4 |
Two Sigma Investments
New York
|
+$2.94M |
| 5 |
BlackRock
New York
|
+$2.66M |
Top Sellers
| 1 | -$92.3M | |
| 2 | -$54.2M | |
| 3 | -$24.4M | |
| 4 |
CC
Casdin Capital
New York
|
-$21.8M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
-$14.8M |